Filtered By:
Management: Economics

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 211 results found since Jan 2013.

Hymenoptera venom immunotherapy: immune mechanisms of induced protection and tolerance - Dem šar Luzar A, Korošec P, Kosnik M, Zidarn M, Rijavec M.
Hymenoptera venom allergy is one of the most severe allergic diseases, with a considerable prevalence of anaphylactic reaction, making it potentially lethal. In this review, we provide an overview of the current knowledge and recent findings in understandi...
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Mechanics & Economics of a Negative Pressure PFT Lab in the COVID-19 Era
Publication date: Available online 30 April 2021Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Timothy C. Olsen, Siu Lam Koo, Robert A. Promisloff, Michael Bohlens, Anthony M. Szema
Source: The Journal of Allergy and Clinical Immunology: In Practice - May 1, 2021 Category: Allergy & Immunology Source Type: research

Single-step direct drug provocation testing is safe for de-labelling selected "non-low-risk" penicillin allergy labels
CONCLUSION: In our cohort, direct single-step DPT was safe with only 6 patients with "non-low risk" allergy experiencing benign reactions. We hope further study can be performed into single-step direct DPT for interrogating "non-low risk" penicillin allergy labels.PMID:33865989 | DOI:10.1016/j.anai.2021.04.008
Source: Annals of Allergy, Asthma and Immunology - April 18, 2021 Category: Allergy & Immunology Authors: Jamma Li Vera Cvetanovski B Nursing Suran Fernando Source Type: research

Single-step direct drug provocation testing is safe for delabelling selected non –low-risk penicillin allergy labels
Penicillin allergy labels are prevalent, and removal of incorrect labels improves patient outcomes and health economics. Labels may be classified as “low-risk” or “non–low-risk,” of which the symptoms of the latter chiefly suggest immunoglobulin E–mediated etiology. Traditionally, “non–low-risk” allergy labels are evaluated by penicillin skin testing followed by graded multistep penicillin drug provocation testing (DPT).
Source: Annals of Allergy, Asthma and Immunology - April 15, 2021 Category: Allergy & Immunology Authors: Jamma Li, Vera Cvetanovski, Suran Fernando Source Type: research

Single-step direct drug provocation testing is safe for de-labelling selected “non-low-risk” penicillin allergy labels
Penicillin allergy labels are prevalent, and removal of incorrect labels improves patient outcomes and health economics. Labels may be classified as "low-risk", or "non-lowrisk", the latter chiefly where symptoms suggest IgE-mediated etiology. Traditionally, "non-low-risk" allergy labels are assessed by penicillin skin testing followed by graded multi-step penicillin drug provocation testing (DPT).
Source: Annals of Allergy, Asthma and Immunology - April 15, 2021 Category: Allergy & Immunology Authors: Jamma Li, Vera Cvetanovski, B. Nursing, Suran Fernando Source Type: research

NIDCR's Spring 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR & NIH Stand Against Structural Racism NIDCR Director Rena D’Souza, DDS, MS, PhD, said in a statement that there is no place for structural racism in biomedical research, echoing remarks from NIH Director Francis Collins, MD, PhD, in his announcement of a new NIH initiative—called UNIT...
Source: NIDCR Science News - April 7, 2021 Category: Dentistry Source Type: news

Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy
Expert Rev Clin Immunol. 2021 Feb 28:1-13. doi: 10.1080/1744666X.2021.1886079. Online ahead of print.ABSTRACTIntroduction: The purpose of this review is to evaluate the cost-effectiveness of allergy immunotherapy (AIT) in the treatment of allergic rhinitis, asthma, and other allergic conditions.Area covered: An extensive search of the PubMed and Medline database (January 1996 up to June of 2020) was conducted using the search terms allergy immunotherapy, pharmacoeconomics, cost-effectiveness, allergic rhinitis, and asthma. Studies were included if they included information on the economics of AIT in comparison to pharmacot...
Source: Expert Review of Clinical Immunology - March 1, 2021 Category: Allergy & Immunology Authors: Linda Cox Source Type: research

Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency
NGS has become a first-line tool for diagnosis of PID. However, patient access remains limited due to restricted insurance coverage and a lack of guidelines addressing use of targeted panels vs WES.
Source: Journal of Allergy and Clinical Immunology - August 31, 2020 Category: Allergy & Immunology Authors: Craig D. Platt, Fatima Zaman, Wayne Bainter, Kelsey Stafstrom, Abuarahman Almutairi, Margot Reigle, Sabrina Weeks, Raif S. Geha, Janet Chou, International Consortium for Immunodeficiencies Source Type: research